BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 61 filers reported holding BEAM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $99,618,202 | -13.0% | 4,142,129 | +15.5% | 0.01% | 0.0% |
Q2 2023 | $114,533,038 | +15.6% | 3,587,004 | +10.8% | 0.01% | 0.0% |
Q1 2023 | $99,088,868 | -59.1% | 3,236,088 | -47.7% | 0.01% | -14.3% |
Q4 2022 | $242,005,718 | +98.2% | 6,187,822 | +141.5% | 0.01% | -12.5% |
Q3 2022 | $122,073,000 | -5.5% | 2,562,409 | -23.2% | 0.01% | 0.0% |
Q2 2022 | $129,149,000 | +13.7% | 3,336,327 | +68.4% | 0.01% | +33.3% |
Q1 2022 | $113,543,000 | -15.3% | 1,981,546 | +17.7% | 0.01% | 0.0% |
Q4 2021 | $134,131,000 | +10.0% | 1,683,163 | +20.1% | 0.01% | 0.0% |
Q3 2021 | $121,964,000 | -28.2% | 1,401,720 | +6.2% | 0.01% | -33.3% |
Q2 2021 | $169,945,000 | +74.3% | 1,320,375 | +8.4% | 0.01% | +50.0% |
Q1 2021 | $97,510,000 | -16.5% | 1,218,271 | -14.8% | 0.01% | -14.3% |
Q4 2020 | $116,779,000 | +792.5% | 1,430,410 | +169.1% | 0.01% | +600.0% |
Q3 2020 | $13,085,000 | +109.3% | 531,478 | +138.0% | 0.00% | – |
Q2 2020 | $6,252,000 | +83.4% | 223,299 | +17.9% | 0.00% | – |
Q1 2020 | $3,409,000 | – | 189,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |